Cadila Healthcare Q1 Net Up 23.14 Per Cent at Rs 240.21 Crore
New Delhi: Cadila Healthcare Ltd on Wednesday reported a 23.14 per cent increase in consolidated net profit at Rs 240.21 crore for the quarter ended June 30, 2014.
The company had posted a net profit of Rs 195.06 crore for the corresponding quarter of financial year 2013-14.
Net sales in the quarter under review rose 25.68 per cent to Rs 2,020.38 crore as against Rs 1,607.45 crore in the year-ago period, the company said in a filing to the BSE.
"Sales growth was buoyed by the company's formulations business in the US, which grew by 88 per cent during the quarter," the company said in a statement.
Overall expenses in Q1 stood at Rs 1,741.71 crore, up 24.55 per cent, compared with Rs 1,398.38 crore in the same quarter of last fiscal year.
Shares in Cadila Healthcare, on Wednesday, ended at Rs 1158.00 apiece on the BSE, up 2.56 per cent from the previous close.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.